Peptides · Peptide comparison
Adrenomedullin vs Intermedin (Adrenomedullin-2)
A powerful vasodilatory peptide that relaxes blood vessels and helps your body maintain healthy fluid balance and blood pressure.
A powerful peptide hormone that protects your heart and blood vessels while managing stress and inflammation naturally.
- Healing & Recovery
- Healing & Recovery
At a glance
Quick comparison
Efficacy
Benefit ratings
Cardiovascular Support
Tissue Protection
Immune Function
Cardiovascular Health & Protection
Stress & Anxiety Management
Anti-Inflammatory & Antioxidant Support
Technical data
Compound specifications
Adrenomedullin
- Molecular formula
- C264H406N80O77S3
- Molecular weight
- 6029 Da (Daltons)
- Half-life
- Approximately 20-30 minutes in plasma (rapid metabolism)
- Bioavailability
- Parenteral administration only; peptide undergoes proteolytic cleavage in circulation
- CAS number
- 148498-78-6
Intermedin (Adrenomedullin-2)
- Molecular formula
- C15H25NO5 (precursor compound)
- Molecular weight
- 299.36 g/mol (precursor)
- Half-life
- Approximately 2-6 hours (varies by route of administration)
- Bioavailability
- Varies by route of administration
- CAS number
- 148498-78-6
Protocols
Dosing compared
Adrenomedullin
Intravenous
- 5 ng/kg/minContinuous infusion, 8 hours per day · 14 days (trial protocol)Adrenomedullin is given as a slow drip into a vein in clinical trials, not by self-injection. This low dose was the bottom step tested for steroid-resistant ulcerative colitis. [4]
- 10 ng/kg/minContinuous infusion, 8 hours per day · 14 days (trial protocol)Middle dose tested in the ulcerative colitis trial. [4]
- 15 ng/kg/minContinuous infusion, 8 hours per day · 14 days (trial protocol)This higher dose was the only one that significantly improved disease scores in the trial. The same 15 ng/kg/min rate was also tested safely in healthy volunteers. [4][5]
Intermedin (Adrenomedullin-2)
No dose levels recorded.
Applications
Best suited for
Adrenomedullin
- Cardiovascular health optimization
- Adrenomedullin is particularly well-suited for individuals focused on cardiovascular health optimization. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Maintaining healthy blood pressure
- Adrenomedullin is particularly well-suited for individuals focused on maintaining healthy blood pressure. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Recovery from illness or sepsis
- Adrenomedullin is particularly well-suited for individuals focused on recovery from illness or sepsis. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Tissue protection and oxygen delivery
- Adrenomedullin is particularly well-suited for individuals focused on tissue protection and oxygen delivery. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Intermedin (Adrenomedullin-2)
- Supporting cardiovascular health and heart function
- Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on supporting cardiovascular health and heart function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Managing inflammation and oxidative stress
- Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on managing inflammation and oxidative stress. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Improving overall vascular health and circulation
- Intermedin (Adrenomedullin-2) is particularly well-suited for individuals focused on improving overall vascular health and circulation. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Safety profile
Side effects
Adrenomedullin
Common
- Mild discomfort at treatment site
- Excessive blood pressure lowering (hypotension)
- Headaches (from pressure changes)
- Flushing and mild facial redness
- Dizziness or lightheadedness
- Mild electrolyte shifts
- Localized injection site reactions
- Increased urination (natriuretic effect)
Serious
- Severe allergic reaction
Intermedin (Adrenomedullin-2)
Common
- Mild discomfort at treatment site
- Flushing and mild facial redness
- Dizziness or lightheadedness
- Mild headache
- Injection site reactions (redness, itching, swelling)
- Nausea or mild gastrointestinal discomfort
- Fatigue or mild energy changes
- Transient hypotension (temporary low blood pressure)
- Mild palpitations (in some individuals)
Serious
- Severe allergic reaction
Research status
Safety & evidence
Adrenomedullin
- Evidence level
- Moderate human trials (Phase 1-2)
- FDA status
- Research compound
- Safety overview
- Adrenomedullin safety in humans is poorly characterized, with clinical data limited to observational studies and small uncontrolled trials in cardiovascular patients. Animal studies demonstrate potent vasodilatory effects that could lower blood pressure dangerously, particularly in patients on antihypertensive medications. No human pharmacokinetic studies have established safe doses, and potential for hypotension, electrolyte disturbances, and off-target vasodilation effects exists. The peptide crosses the blood-brain barrier and affects central nervous system function in animal models, raising concerns about neurological effects at higher doses.
Contraindications
- Severe hypotension or shock states
- Concurrent use with certain vasopressor medications
- Pregnancy and breastfeeding
- Severe kidney or liver dysfunction
Intermedin (Adrenomedullin-2)
- Evidence level
- Limited human trials
- FDA status
- Not FDA approved
- Safety overview
- Intermedin (Adrenomedullin-2) is an endogenous peptide hormone with systemic vascular and renal effects that warrant cautious use. As a vasodilator acting through CGRP and other peptide receptors, it can significantly lower blood pressure—a key safety consideration for hypotensive or cardiovascular-compromised individuals. Preclinical studies show dose-dependent hypotensive effects and tachycardia, limiting clinical translation. The compound remains largely experimental with limited safety data in humans outside specific research contexts.
Contraindications
- Pregnancy and breastfeeding - insufficient safety data
- Active cardiovascular events (heart attack, stroke)
- Severe renal (kidney) impairment
- Hypersensitivity to calcitonin family peptides
- Uncontrolled endocrine disorders
Decision guide
Which is right for you?
Adrenomedullin
Choose Adrenomedullin if…
- Cardiovascular health optimization
- Maintaining healthy blood pressure
- Recovery from illness or sepsis
- Tissue protection and oxygen delivery
Intermedin (Adrenomedullin-2)
Choose Intermedin (Adrenomedullin-2) if…
- Supporting cardiovascular health and heart function
- Managing inflammation and oxidative stress
- Improving overall vascular health and circulation